| Total (N = 5474) | With incident T2DM (N = 577) | Without incident T2DM (N = 4897) | P-value |
---|---|---|---|---|
Continuous variables | ||||
 Age (year) | 41.3 ± 13.6 | 46.7 ± 12.7 | 40.6 ± 13.6 | < 0.001 |
 SBP (mmHg) | 116.95 ± 17.1 | 124.2 ± 18.2 | 116.1 ± 16.8 | < 0.001 |
 DBP (mmHg) | 76.6 ± 10.4 | 80.8 ± 10.5 | 76.1 ± 10.2 | < 0.001 |
 Baseline BMI (kg/m2) | 26.7 ± 4.5 | 29.1 ± 4.6 | 26.4 ± 4.4 | < 0.001 |
 Baseline WC (cm) | 87.6 ± 11.8 | 94.6 ± 11.1 | 86.8 ± 11.6 | < 0.001 |
 Baseline FPG (mmol/L) | 4.95 ± 0.51 | 5.36 ± 0.60 | 4.90 ± 0.47 | < 0.001 |
 TC (mmol/L) | 5.29 ± 1.16 | 5.74 ± 1.26 | 5.24 ± 1.13 | < 0.001 |
 LnTG | 0.44 ± 0.54 | 0.70 ± 0.52 | 0.40 ± 0.54 |  |
 HDL-C (mmol/L) | 1.09 ± 0.28 | 1.06 ± 0.27 | 1.09 ± 0.28 | 0.005 |
 LDL-C (mmol/L) | 3.37 ± 0.94 | 3.68 ± 1.00 | 3.33 ± 0.92 | < 0.001 |
 Non-HDL-C (mmol/L) | 4.20 ± 1.16 | 4.68 ± 1.25 | 4.15 ± 1.14 | < 0.001 |
 LnTG/HDL-C | 0.38 ± 0.69 | 0.68 ± 0.65 | 0.35 ± 0.69 |  |
 TC/HDL-C | 5.16 ± 1.68 | 5.70 ± 1.73 | 5.09 ± 1.66 | < 0.001 |
 BMI change (Kg/m2) | 0.79 ± 1.97 | 0.98 ± 2.50 | 0.77 ± 1.90 | 0.06 |
 WC change (cm) | 3.64 ± 6.79 | 3.99 ± 6.60 | 3.59 ± 6.81 | 0.18 |
 FPG change (mmol/L) | 0.03 ± 0.50 | 0.16 ± 0.57 | 0.02 ± 0.49 | < 0.001 |
Categorical variables | ||||
 Male | 2320(42.4) | 237(41.1) | 2083(42.5) | 0.53 |
 Hypertension (%) | 951 (17.4) | 174(30.2) | 777(15.9) | < 0.001 |
 Family history of T2DM (%) | 1397(25.5) | 212(36.7) | 1185(24.2) | < 0.001 |
 CVD history (%) | 171(3.1) | 30(5.2) | 141(2.9) | 0.005 |
 Education level (%) |  |  |  | < 0.001 |
   ≥ 12 years | 752(13.7) | 51(8.8) | 701(14.3) |  |
  6–12 years | 3070(56.1) | 276(47.8) | 2794(57.1) |  |
   < 6 years | 1652(30.2) | 250(43.3) | 1402(28.6) |  |
 Intervention (%) | 2425(44.3) | 239(41.4) | 2186(44.6) | 0.14 |
 Smoking (%) |  |  |  | 0.74 |
  Never or past | 4832(88.4) | 513(89.1) | 4319(88.3) |  |
  Current | 634(11.6) | 63(10.9) | 571(11.7) |  |
 Lipid drug use (%) | 125(2.3) | 27(4.7) | 98(2.0) | < 0.001 |